These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2330861)

  • 61. [The effect of procainamide on the inducibility of ventricular tachycardia using programmed stimulation].
    Lukl J; Heinc P; Cernosek B
    Vnitr Lek; 1989 Nov; 35(11):1049-56. PubMed ID: 2623834
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Hemodynamics in ventricular arrhythmias and in their treatment].
    Lüderitz B; Manz M
    Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
    Long B; Koyfman A
    J Emerg Med; 2017 Apr; 52(4):484-492. PubMed ID: 27751700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.
    Holzberger PT; Greenberg ML; Paicopolis MC; Ozahowski TP; Ho PC; O'Connor GT
    Am Heart J; 1998 Jul; 136(1):49-56. PubMed ID: 9665218
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
    Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
    Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia.
    Aroesty JM; McKay RG; Heller GV; Royal HD; Als AV; Grossman W
    Circulation; 1985 May; 71(5):889-900. PubMed ID: 3986979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of intravenous N-acetylprocainamide on hemodynamics and left ventricular function in man.
    Josephson MA; Schwab M; Coyle K; Singh BN
    Am Heart J; 1987 Apr; 113(4):952-7. PubMed ID: 2436466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group.
    Singh BN; Kehoe R; Woosley RL; Scheinman M; Quart B
    Am Heart J; 1995 Jan; 129(1):87-97. PubMed ID: 7817931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease.
    Goldberg D; Reiffel JA; Davis JC; Gang E; Livelli F; Bigger JT
    Am Heart J; 1982 Jan; 103(1):75-9. PubMed ID: 7055048
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block.
    Schwartz AB; Shapiro WA; Suave MJ; Shen E; Bhandari A; Morady F; Scheinman M
    Can J Cardiol; 1987 Mar; 3(2):75-82. PubMed ID: 3105850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Procainamide in the dog: antiarrhythmic plasma concentrations after intravenous administration.
    Papich MG; Davis LE; Davis CA
    J Vet Pharmacol Ther; 1986 Dec; 9(4):359-69. PubMed ID: 3806778
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Massive doses of procainamide for ventricular tachyarrhythmias due to myocardial infarction.
    Mattiasson I; Hanson A; Johansson BW
    Acta Med Scand; 1978; 204(1-2):27-34. PubMed ID: 685726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ventricular tachycardia: its treatment with emphasis on recent changes in therapy.
    Van Cleve RB
    South Med J; 1967 Aug; 60(8):897-8. PubMed ID: 6036662
    [No Abstract]   [Full Text] [Related]  

  • 76. Bolus Intravenous Procainamide in Patients with Frequent Ventricular Ectopics during Cardiac Magnetic Resonance Scanning: A Way to Ensure High Quality Imaging.
    Nikolaidou C; Kouskouras K; Fragakis N; Vassilikos VP; Karvounis H; Karamitsos TD
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33513676
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypersensitivity reaction associated with acute hepatic dysfunction following a single intravenous dose of procainamide.
    Worman HJ; Ip JH; Winters SL; Tepper DC; Gomes AJ
    J Intern Med; 1992 Oct; 232(4):361-3. PubMed ID: 1402640
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ventricular tachycardia in infancy.
    Anthony CL; Stuart LD; Plunket DC; Czarnecki SW
    Am J Dis Child; 1966 Nov; 112(5):469-75. PubMed ID: 5917982
    [No Abstract]   [Full Text] [Related]  

  • 79. High-dose procainamide in chronic renal failure.
    Bottorff MB; Kuo CS; Batenhorst RL
    Drug Intell Clin Pharm; 1983 Apr; 17(4):279-81. PubMed ID: 6839958
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased procainamide plasma concentrations caused by quinidine: a new drug interaction.
    Hughes B; Dyer JE; Schwartz AB
    Am Heart J; 1987 Oct; 114(4 Pt 1):908-9. PubMed ID: 3661379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.